Page

We Help Pharma Whistleblowers Report Off-Label Marketing Fraud and Maximize Cash Awards Off-label marketing is one of the most dangerous types of pharmaceutical fraud. Promoting medications for FDA unapproved uses or unapproved dosages continues to harm thousands of American consumers and waste...

Drug sales reps have a front-row seat to illegal marketing schemes. The role of drug marketing is to promote drugs for FDA-approved uses, but pharmaceutical companies have a track record of paying illegal kickbacks and inducing prescriptions for off-label uses of their...

Pharmaceutical Integrity Coalition is looking for well-placed pharma industry insiders with information about financial fraud. Our attorneys and advocates are currently investigating claims of fraud by drugmakers in New York, California, Texas, Florida, Illinois, Washington, and many other...

We Help Pharmaceutical Professionals Report Fraud and Maximize Cash Awards Pharmaceutical companies, drug manufacturers, biotechnology outfits, medical device manufacturers and other companies regulated by the U.S. Food and Drug Administration (FDA) continue to engage in fraud, waste and abuse of...

We Help Pharmaceutical Whistleblowers Report cGMP Violations and Maximize Cash Awards With today’s immense market for prescription drugs, pressure to meet demand has many drug manufacturers ignoring FDA current good manufacturing practices (cGMP) requirements and overall quality control....

Companies that violate good manufacturing practices (“GMPs”) and/or good clinical practices, as well as the respective FDA 21CFR Sections 201, 211 and 312, 314 regulations, may be in violation of federal and state False Claims Acts when the resulting substandard or adulterated products...